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Introduction
MicroRNAs are small (19-24 nucleotides) , non-coding RNA molecules that regulate gene expression at the post-transcriptional level and hundreds of microRNAs have been discovered and investigated to date [1] . A single microRNA can regulate the expression of more than 100 genes. In turn, a gene may be targeted by several microRNAs. Given the large number of miRNAs annotated in the human genome, 30%-80% of human genes are predicted to be regulated by miRNAs [2; 3; 4; 5; 6; 7] . Specifically, aberrant microRNA profiles have been observed in various cancer types, which may be a result of epigenetic alterations of miRNA promoters, the altered activity of transcriptional factors or dysregulated enzymes involved in miRNA biogenesis [8] . Furthermore, altered microRNA expression contributes to cancer development by down-regulating tumor suppressor genes or up-regulating tumor-promoting oncogenes [9] .
Melanoma is an aggressive skin cancer whose incidence rate has been increasing within white-skinned populations [10] . The survival of patients with melanoma depends on tumor thickness, which is one of the most important prognostic factors. Therefore, the early detection of the tumor is crucial for a successful treatment, and the detection of changes in the micro-RNA profile in tumor tissue may serve as a tool for identification of novel molecular markers. Recent studies showed that melanoma progression is accompanied by significant dysregulation of the microRNA expression pattern [11, 12] , but a specific microRNA has not yet been shown as an adequate marker to diagnose and predict the prognosis of patients with this disease. This challenge may be due to tumor heterogeneity, which complicates the differentiation of microRNA expression pattern between tumor and tumor microenvironment cells. Conversely, the tissue microRNA expression pattern is relatively stable and specific under different pathological states. Specifically, a recent study [13] identified the following five microRNAs to be strongly associated with the outcome of patients with melanoma: miR-142-5p, miR-150-5p, miR-342-3p, miR-155-5p, and miR-146b-5p. Unfortunately, the serum-derived microRNAs of these patients correlate only with the microRNA tissue pattern at the late stage but not with primary tumors which currently complicates the use of microRNA identification as prognostic or diagnostic approach for melanoma [14] . Thus, additional studies are necessary to clarify the exact role of altered microRNAs in tumor development and progression as well as their clinical importance. MiR-4286 was shown to be up-regulated in different types of malignancies such as pancreatic cancer [15] , glioma [16] , and esophageal adenocarcinoma [17] . Furthermore, Sand M. et al. included miR-4286 in a list of significantly up-regulated microRNAs in melanoma whose role in melanomagenesis has not been studied [18] .
The aim of this study was to compare the microRNA expression profiles in melanoma and melanocytic nevi in order to identify a specific pattern and study the function of aberrantly expressed microRNAs in melanoma.
Materials and Methods

Tissue samples
The study was approved by the Krasnoyarsk State Medical University Local Ethics Committee (protocol №59/2014 issued on December 2, 2014). Written consent was approved by the Local Ethics Committee and obtained from all participants in the study before obtaining samples. Treatment-naive primary melanoma and benign melanocytic tumor samples were obtained from patients at the Krasnoyarsk Regional Oncology Center, which is named after A.I. Kryzhanovsky. Sixteen melanoma and 3 melanocytic nevi samples were fixed in formalin and embedded in paraffin. The ages of patients with melanoma ranged from 35 to 81 years. Men comprised 56% and females-44% of the cohort (Table 1) . The ages of patients with melanocytic nevi ranged from 29 to 55 years. Two patients had nevi on the face, whereas one was with nevus on the breast ( Table 2) . Samples of melanocytic lesions containing less than 70% of studied cells were macrodissected to separate the tissues from melanoma cells and tumor microenvironment. The percentage of target tissue in each sample was evaluated by hematoxylin/eosin staining and subsequent light microscopy.
Samples were processed according to a standard protocol that included incubation in 10% neutral buffered formalin for 24 h and embedding in paraffin blocks. The diagnosis was made by a certified pathologist at the Krasnoyarsk Pathologic Anatomy Bureau. After fixation, the samples were stored in the Archive of Pathologic Anatomy Bureau at room temperature for up to 5 years.
RNA isolation
Total RNA was isolated using the RecoverAll™ Total Nucleic Acid Isolation kit (Ambion, Life Technologies, Vilnius, Lithuania). Formalin-fixed and paraffin-embedded (FFPE) samples were sectioned at a thickness of 15 μm, deparaffinized with xylene, and washed twice with ethanol according to the standard procedure. The tissues were then suspended in 200 μl of Digestion buffer. RNA was isolated according to manufacturer's instructions for RNA isolation and eluted with 50 μl of nuclease-free water. The microRNA concentration was measured on Qubit1 2.0 fluorimeter (Invitrogen by Life Technologies, Singapore, Singapore) using the Qubit1 microRNA Assay kit (Ref. Q32880, Eugene, Oregon, USA). The concentration of microRNA in the samples submitted to the microarray analysis exceeded 16.3 ng/μl. 
TaqMan miRNA real-time PCR
In this work, the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines was applied for data reporting [20] . The reverse transcription reaction was performed in a reaction mixture containing 0.4 μl of 5x primers miRNA TaqMan assays specific to the investigated microRNA (Cat. № 4427975, Applied Biosystems, Foster City, CA, USA) or Random-primers for mRNA expression analysis, 0.4 μl of OT-buffer, 0.05 μl revertase enzyme, and 0.15μl of RNA-eluent solutions from the "Reverta" kit (AmpliSens, Moscow, Russia) per 1 μl of isolated RNA. The reactions were carried out at 37˚C for 30 min. cDNA was immediately used for the RT-PCR reaction or stored at -20˚C. Briefly, the obtained cDNA was added to a PCR cocktail containing 8 μl of the 2.5-fold RT-PCR reaction mixture and ROX reference dye (Syntol, Moscow, Russia), 1 μl of 20x primers, miRNA TaqMan assay probe mix, and deionized water to a total volume of 20μl. U6snRNA and RNU6B (Cat. № 001973, Assay ID 001973 and 4427975 respectively, Applied Biosystems, Foster City, CA, USA) were used as endogenous controls to estimate the relative microRNA expression levels; beta-actin (Cat. № 4331182, Assay ID Hs01060665_g1) and HPRT-1 (hypoxanthinephosphoribosyltransferase 1) (Cat. № 4331182, Assay ID Hs01003267_m1) were used as endogenous controls to evaluate mRNA levels. The reaction was performed on a StepOne™ Real-Time PCR System (Applied Biosystems, Singapore, Singapore) with the following temperature cycling protocol: 50˚C for 2 min and 95˚C for 10 min, followed by 40 cycles of 95˚C for 15 sec and 60˚C for 1 min with FAM/VIC detection. Three replicates were performed for each experiment. The microRNA or mRNA expression was normalized to the geometric mean of U6 snRNA and RNU6B or beta-actin and HPRT-1, respectively, as described previously [21] . The data were analyzed using the ΔΔC t method.
Cell culture and transfection
The human melanoma cell line BRO [22; 23] Technologies, Carlsbad, CA, USA) using real-time PCR and 5X specific from primers of TaqMan MicroRNA Assay (Cat. № 4427975, Assay ID 241500_mat, Applied Biosystems, Foster City, CA, USA), as described above. The experiments were performed in triplicate. KEGG pathway analysis of miRNA target genes DIANA-mirPath v.3.0 was used for the KEEG pathway analysis of the miRNA signature. MiRNA targets were predicted based on DIANA-microT-CDS and heatmaps were generated using the log-transformed enrichment p-values as features for each miRNA. The threshold (Pvalue 0.05 and false discovery rate (FDR) 0.05) was calculated using Fisher's exact test.
Cell apoptosis detection
To predict the gene targets of hsa-miR-4286, three different algorithms, TargetScan 7.0, miRWalk 2.0, and miRTarBase v.4.5 were applied to identify the validated targets of hsa-miR-4286. To reduce the false-positive results, only genes identified by all three methods were selected as miRNA targets to be subsequently analyzed. Cumulative context score was applied to choose most targeted genes for miR-4286. The PANTHER™ v.10.0 classification system was used to interpret the biological function of the validated targets of hsa-miR-4286.
Statistical analysis
The Expression Console and Transcriptome Analysis Console 2.0 (Affymetrix, USA) software were used for quality control, statistical analysis and miRNA annotation. The data were automatically statistically analyzed using ANOVA test and FDR-corrected values. MicroRNAs expression differences were assessed using a Mann-Whitney U-test and considered significant at p 0.05. The hierarchical clustering of differently expressed microRNAs was generated by the Transcriptome Analysis Console 2.0 software (Affymetrix, Santa Clara, CA, USA). Realtime PCR data were analyzed by using the ΔΔC t method and a nonparametric Mann-Whitney U-test with the Statistica 6.1 software (StatSoft, Moscow, Russia). The data on cell proliferation, viability, apoptosis, migration, and invasion were analyzed using a nonparametric MannWhitney U-test. The differences were considered significant at p < 0.05.
Results
MicroRNA expression in melanoma and melanocytic nevi from FFPE tissues
A microarray analysis of FFPE-embedded samples identified 1,600 of 6,631 short non-coding RNAs that exhibited an at least 2-fold difference in expression between melanoma and melanocytic nevi samples. Of these RNAs, 1,171 were classified as microRNAs. Specifically, 674 microRNAs were up-regulated and 497 -down-regulated in melanoma (S1 Table) . The largest differences were observed in miR-155-5p, miR-1246, let-7i-5p, miR-34a-5p, miR-652-3p, and miR-4530, which were up-regulated, and in miR-211-5p, miR-5196-3p, miR-6804-3p, miR-6809-3p, and miR-6736-3p, which were down-regulated. The hierarchical clustering clearly differentiated between the melanoma and nevus groups based on miRNA expression profiles (Fig 1) .
Real-time PCR
The miR-363-3p, miR-513a-5p, and miR-3591-3p expression levels in melanoma and melanocytic nevi samples were measured by real-time PCR to confirm the microarray data. The MiR513a-5p, miR-363-3p, and miR-3591-3p were selected for this analysis because they exhibited a wide range in expression differences between melanoma and melanocytic nevi samples: a preliminary microarray showed that miR-363-3p was 8.65-fold over-expressed, miR-3591-3p was 16.18-fold down-regulated and miR-513a-5p expression did not significantly differ between melanoma and nevi samples. Moreover, after adjusting p-values with FDR, the significance of miR-363-3p changes was lost, what required confirmation by real-time PCR. Furthermore, these molecules were of different size (18, 22 , and 23 nucleotides for miR-513a-5p, miR-363-3p, and miR-3591-3p, respectively) and exhibited GC contents of 34.78% (miR-3591-3p), 40.91% (miR-363-3p), and 50.00% (miR-513a-5p). Moreover, previous studies indicated that matched microRNAs are involved in carcinogenesis [26, 27, 28] . Real-time PCR confirmed the microarray data obtained after FDR correction: miR-363-3p and miR-513a-5p expression did not significantly differ between melanoma and melanocytic nevi, whereas miR-3591-3p was down-regulated in melanoma compared to melanocytic nevi (Fig 2, S2 Table) .
The efficiency of cell transfection with anti-miR-4286 was estimated based on a real-time PCR analysis of HMGA2 expression in the transfected cells. Specifically, transfected BRO and SK-MEL-1 cells with let-7c miRNA inhibitor resulted in a 30% increase in HMGA2 expression compared to the negative control (p = 0.0495), (Table 3) . Furthermore, real-time PCR determined that the miR-4286 levels were down-regulated in both anti-miR-4286 transfected cell types compared to the negative control (p = 0.0495), (data are presented in Fig 3, S3 Table) . 
Signal pathway analysis
The study of FFPE-embedded tissues identified 52 signaling pathways as significantly modulated. Specifically, fatty acid biosynthesis, elongation, metabolism, AMPK signaling, actin cytoskeleton regulation, and melanoma pathways were altered in melanoma compared to benign melanocytic lesions.
Furthermore, melanoma samples exhibited alterations in the Hippo, viral carcinogenesis, TGF-beta signaling, cell cycle and adherens junction pathways. The full list of signaling pathways associated with differently expressed microRNAs is presented in S4 Table.
MiR-4286
Furthermore, miR-4286 was more than 17.8-fold up-regulated in melanoma compared to benign melanocytic tumors in our study. Thus, we carried out a biometrical analysis of target genes of miR-4286 and a functional study of its activity using a miR-4286 specific inhibitor that was transfected in melanoma cells.
Gene target analysis for miR-4286
The three algorithms (as mentioned in Materials and methods section) predicted 94 as the targets of hsa-miR-4286. Our bioinformatic studies have suggested that hsa-miR-4286 regulates a large number of target genes that are important for the regulation of crucial cell processes: cell proliferation (APLN, FPGS, FTSJ2, FURIN, HMGA1 , RAPGEF3, RRN3, RPS6, and TP53); angiogenesis (PIK3C2B, MAPK1 KSR1, and RAPGEF3); cell fate, cell survival, metabolism, cell death, cell division, and mitosis (PIK3C2B, MAPK1, REL, TP53, FBXO18, RABGAP1, SLFN5, TMEM109, TRAF3, and ZBTB7A); glucose, lipids, nucleic acids, and amino acids metabolism, as well as ion transport (ACBD7, APOL6, ATP1A3, ATP13A4, CACNA1E, LDLR, MAN1A2, PGK1, PRKAG1, RIMS3, SCNN1G, SLC39A13, SLC6A17, TMEM151B, and TRPC4AP); and adhesion molecules (CLDN1, SEMA4D, and SIRPA). S5 Table shows the complete list of biological functions of miR-4286 target genes. Table 3 . Expression levels of HMGA2 by PCR real-time as indicators of transfection efficiency (normalized by the geometric mean of β-actin and HPRT-1 expression levels).
Cell line
Relative quantity, mean ± SEM P Cell viability/proliferation assay. An MTT assay was performed 24, 48, 72, and 96 h after transfecting the cells with the miR-4286 inhibitor. As Fig 4 suggests , the inhibition of miR-4286 activity significantly decreased the viability/proliferation of BRO melanoma cells at each time point, whereas SK-MEL-1 cell proliferation was decreased only at the 96-h time point (Fig 4, S6 Table) .
Apoptosis detection. To further investigate the effect of miR-4286 on apoptosis in cancer cells we transfected cells with the miR-4286 inhibitor and examined its effect on melanoma cells. Flow cytometry showed that miR-4286 inhibition in BRO melanoma cells increased the apoptosis rate 2.6-fold and the number of melanoma cells in the pre-apoptotic phase also increased 2-fold (Fig 5, S7 Table) . A fluorescence microscopy assay revealed increase in the caspase 3/7 activity in miR-4286-inhibitor transfected cells.
Migration, invasion analysis. We performed an in vitro cell invasion and migration assay to further determine if miR-4286 affects cell invasion and migration. The inhibition of miR- Table. These results suggest that the down-regulation of miR-4286 does not inhibit the migratory and invasive capacities of melanoma cells in vitro.
MiR-4286 gene targets validation by real-time PCR after miR-4286 inhibitor application. To understand the mechanism by which miR-4286 affects cell proliferation and apoptosis, we studied the expression levels of miR-4286 target genes that regulate these processes. Indeed, miR-4286 inhibition resulted in degradation of folylpolyglutamate synthase, RNA polymerase I-specific transcription initiation factor, apelin, G-protein-coupled receptor 55, and high-mobility group A1 protein mRNA in BRO melanoma cells, as measured by real-time PCR (Fig 7, S9 Table) . In SK-MEL-1 cells, only the expression of folylpolyglutamate synthase was down-regulated (Fig 8, S9 Table) . 
Discussion
MicroRNA in melanoma versus melanocytic nevi
Several studies have attempted to reveal differences in the miRNA expression profile between melanoma and benign melanocytic tumor tissues. The data reported herein are partially consistent with previously reported findings. Specifically, we found that miR-211 [29; 30; 31] , miR-204 [28; 29] , miR-23b-3p [28; 29] , miR-26a-5p [29; 32] , and miR-146a-5p [29] were down-regulated, whereas miR-155-5p was up-regulated [13; 28; 33] , as also described earlier.
The present study identified several novel microRNAs aberrantly expressed in melanoma compared to melanocytic nevi. Specifically, the investigation of FFPE melanocytic tumors showed that miR-4454 and miR-7975, whose functions have not yet been studied, were overexpressed.
A pathway analysis revealed that fatty acid biosynthesis, elongation, degradation, and metabolism were altered in melanoma samples compared to nevi samples. The previous studies showed that the fatty acids play a role in melanomagenesis. In contrast to most normal cells, fatty acid synthase is overexpressed in a variety of human cancers, including cutaneous melanoma, in which its elevated expression levels are associated with tumor invasion and poor prognosis. Furthermore, fatty acid synthase inhibition induced apoptosis in melanoma cells [34] . Other aberrantly activated pathways in melanoma compared to melanocytic nevi include the AMP-activated protein kinase (AMPK), hippo and transforming growth factor-beta (TGFbeta) signaling pathways. AMPK is known as an important regulator of cellular energy homeostasis and has been shown to control tumor progression by regulating the cell cycle, protein synthesis, cell growth and survival [35] .
Hippo signaling was first described to suppress proliferation and induce apoptosis. Moreover, the Hippo signaling pathway is also responsible for cell-cell adhesion interactions during metastasis development, and it has been also described to play a role in cancer stem cell regulation [36] . TGF-beta is a pleiotropic regulator of cancer cell activity that affects cell proliferation, apoptosis, differentiation, and immune function [37] . Specifically, TGF-beta induces epithelial-to-mesenchymal-like transitions in melanoma cells and peritumoral angiogenesis [38; 39] ; recent studies by Fedorenko et al. showed that treating melanoma cells with vemurafenib induce fibroblasts activity by releasing TGF-beta, which leads to therapeutic resistance [40] .
Impact of miR-4286 on melanoma cells behavior
The inhibition of miR-4286 led to diminishing cell proliferation rate in both melanoma cell lines and triggered an increase in BRO apoptotic melanoma cells as indicated by elevated numbers of Annexin V+/7AAD-detected by flow cytometry. Unfortunately, Annexin V/7AAD staining does not allow to clearly differentiate late apoptosis and necrosis. Our data show that inhibition of miR-4286 increases the apoptosis and necrosis of BRO melanoma cells that is partially referable to the apoptosis induction. Moreover, the inhibition of miR-4286 down-regulated the expression of its targets. Taken together, these findings suggest that miR-4286 is involved in cell proliferation and apoptosis regulation. Apelin modulates these processes via PI3/Akt signaling pathway [41, 42] , and G protein-coupled receptor 55 triggers MAPK cascade [43] . Furthermore, high-mobility group A1 protein is involved in Wnt/β-catenin pathway [44] . SK-MEL-1 melanoma cells proliferation was altered after miR-4286 inhibitor application, which matched the changes in the levels of folylpolyglutamate synthase (FPGS), an enzyme crucial for survival of dividing cells. FPGS expression levels showed different tendencies in BRO and SK-MEL-1 cells. This phenomenon can be explained by different action of FPGS in melanoma cells due to its oxidative status. Melanoma metastases of visceral organs (BRO melanoma cells) are more subjected to oxidative stress that leads to FPGS activation as folate metabolism is a major source of NADPH for oxidative stress reactions. On the contrary, primary tumors and regional lymph nodes metastasis (SK-MEL-1) showed a reduced expression of folate metabolism enzymes because oxidative stress reactions are not present [45] . MiR-4286 does not target p53 since its levels were not altered after miR-4286 inhibitor application that may be due to the activation of p53-independent apoptosis in cells.
Conclusion
The obtained data demonstrate that miR-4286 contributes to the regulation of melanoma cell proliferation and apoptosis by triggering several pathways, suggesting that it exerts a pleotropic effect. 
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